Parenteral Manufacturing and Industry 4.0

Jul 19, 2016

Industry 4.0 will be a game changer in how the patient will interact with all the partners who are involved in all aspects of the wellbeing of the end-user. Real-time data on the status of the health situation of the individual will have the possibility of flowing seamlessly to an array of partners. Morten Munk and Gert Moelgaard at NNE Pharmaplan submit an overview of parenteral manufacturing. ...

Read More

Comparison of Good Manufacturing Practice Compliance Requirements – European Union, United States and India

Jul 19, 2016

The intentions of the current study are to expedite the compliance requirements to support the regulatory approval for selected pharmaceuticals in the United States, the European Union and India. The literature search is done using different resources like regulatory authority websites, pharmaceutical review articles, journals and public domain. To ensure the quality, all pharmaceutical manufacturers are required to establish and implement effective quality management systems. B. Naga Vamsi, Balamuralidhara V., Shenaz Z Khaleeli and Srinath S from JSS College of Pharmacy compare the GMP compliance requirements in Europe, the US and India. ...

Read More

Digital Health: Increasing the Quality and Efficiency of Care

Jul 19, 2016

New technologies allow for direct patient care and necessitate an overhaul in the focus of healthcare industry business models. It is becoming clear that in order to stay relevant in the future healthcare ecosystem, pharma companies must look to business models that foster much more direct patient engagement than previously. New methods offer significant potential in increasing the quality and efficiency of care. Digital health solutions could therefore solve the major long-term issues of pharma’s most important client groups – patients, providers and payers – all at the same time. Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré and Richard Beetz ...

Read More

The Digital Age: Tackling the Challenges and Embracing the Opportunity

Jul 19, 2016

The life sciences industry has always been incredibly innovative in its R&D and bringing new life-saving and -changing medicines, devices, diagnostic tools and products to market. However, it has often been a late adopter of new communication technologies, platforms, and channels – perhaps understandably, given the highly-regulated life sciences operating environment. In this digital age, with information instantly available with a few keyboard strokes or taps on the latest smartphone or wearable, our world is changing exponentially, and with it, the needs, wants, and demands of patients, carers, healthcare providers, and payers across the globe. Susan Macdonald, Founder and Director ...

Read More

Reinventing Data Management, with R&D at the Centre

Jul 19, 2016

R&D generates a wealth of vital data, which is pivotal to everything else a life sciences organisation does. Yet there is often great diversity in the way this is collected, retained and accessed. This lack of consistency compromises the ability to track products effectively, both within the business and out in the market. The new ISO Identification of Medicinal Products (IDMP) standards couldn’t have come at a better time then, says Steve Scribner, life sciences advisor to AMPLEXOR Group. ...

Read More